Abstract
Readers of the medical literature doubtless find the asbestos-associated diseases a complex topic. The two reports on this subject in a recent issue ofThe Journaldoubtless contribute to the confusion expressed by many physicians. In the first, Dodson et al 1 record the results of assays of pulmonary tissue from three quite different but relatively small groups of subjects. In contrast to the findings of other investigators, 2-7 these workers failed to detect ferruginous bodies in the lungs of urban residents and rural patients with bronchogenic carcinoma. Several technical considerations and problems of tissue sampling and patient selection could have contributed to the discrepancies between this and earlier reports, but one must ask if the findings are important in the overall context of our understanding of the diseases associated with exposure to asbestos. It is now widely recognized that most of the ferruginous bodies in the lungs of members
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
